CHARLES SCHWAB INVESTMENT MANAGEMENT INC - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$627,433
+7.0%
65,1540.0%0.00%
Q2 2023$586,386
+16.8%
65,154
+2.0%
0.00%
Q1 2023$501,995
+17.7%
63,867
+1.2%
0.00%
Q4 2022$426,664
-53.4%
63,1160.0%0.00%
Q3 2022$916,000
+48.0%
63,116
+0.3%
0.00%
Q2 2022$619,000
-28.2%
62,899
+7.7%
0.00%
Q1 2022$862,000
+13.4%
58,415
+1.7%
0.00%
Q4 2021$760,000
-16.5%
57,415
+10.2%
0.00%
Q3 2021$910,000
-21.1%
52,098
+8.2%
0.00%
Q2 2021$1,154,000
-4.2%
48,161
+2.7%
0.00%
Q1 2021$1,205,000
+88.9%
46,897
+39.6%
0.00%
Q4 2020$638,000
+63.2%
33,587
+8.4%
0.00%
Q3 2020$391,000
-0.5%
30,990
-4.4%
0.00%
Q2 2020$393,000
+71.6%
32,421
+8.7%
0.00%
Q1 2020$229,000
-57.0%
29,8290.0%0.00%
Q4 2019$532,000
+67.8%
29,829
+9.3%
0.00%
Q3 2019$317,000
-47.6%
27,2930.0%0.00%
Q2 2019$605,00027,2930.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders